HKAM
BMY icon

Horizon Kinetics Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Horizon Kinetics Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Sell
44,706
-404
-0.9% -$23.6K 0.03% 99
2025
Q4 		$2.43M Buy
45,110
+197
+0.4% +$9.48K 0.03% 100
2025
Q3 		$2.03M Sell
44,913
-16,404
-27% -$766K 0.02% 116
2025
Q2 		$2.84M Buy
61,317
+1,504
+3% +$73.8K 0.03% 103
2025
Q1 		$3.65M Sell
59,813
-663
-1% -$38.6K 0.04% 83
2024
Q4 		$3.42M Buy
60,476
+1,094
+2% +$61.1K 0.04% 89
2024
Q3 		$3.07M Buy
59,382
+14,364
+32% +$674K 0.05% 96
2024
Q2 		$1.87M Buy
45,018
+1,530
+4% +$68.5K 0.03% 112
2024
Q1 		$2.36M Buy
43,488
+952
+2% +$48.5K 0.04% 91
2023
Q4 		$2.18M Buy
42,536
+155
+0.4% +$8.14K 0.05% 91
2023
Q3 		$2.46M Sell
42,381
-150
-0.4% -$9.19K 0.05% 85
2023
Q2 		$2.72M Hold
42,531
– – 0.06% 86
2023
Q1 		$2.95M Sell
42,531
-4,937
-10% -$348K 0.06% 76
2022
Q4 		$3.42M Sell
47,468
-333
-0.7% -$25.1K 0.06% 73
2022
Q3 		$3.4M Buy
47,801
+220
+0.5% +$16K 0.07% 69
2022
Q2 		$3.66M Sell
47,581
-283
-0.6% -$21.6K 0.08% 70
2022
Q1 		$3.5M Sell
47,864
-120
-0.3% -$8.06K 0.07% 84
2021
Q4 		$2.99M Buy
47,984
+975
+2% +$57.2K 0.07% 95
2021
Q3 		$2.78M Sell
47,009
-700
-1% -$46.1K 0.07% 98
2021
Q2 		$3.19M Sell
47,709
-12
-0% -$782 0.06% 95
2021
Q1 		$3.01M Sell
47,721
-20
-0% -$1.24K 0.07% 90
2020
Q4 		$2.96M Sell
47,741
-3,133
-6% -$193K 0.1% 86
2020
Q3 		$3.07M Sell
50,874
-160
-0.3% -$9.63K 0.12% 78
2020
Q2 		$3M Sell
51,034
-1,888
-4% -$113K 0.11% 78
2020
Q1 		$2.95M Sell
52,922
-2,396
-4% -$146K 0.13% 72
2019
Q4 		$3.55M Buy
55,318
+7,000
+14% +$401K 0.1% 69
2019
Q3 		$2.45M Sell
48,318
-85
-0.2% -$4K 0.07% 92
2019
Q2 		$2.19M Buy
48,403
+1,615
+3% +$75.2K 0.06% 109
2019
Q1 		$2.23M Buy
+46,788
New +$2.33M 0.06% 111

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Horizon Kinetics Asset Management's BMY Position: Q1 2026 in Review

Horizon Kinetics Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.9% in Q1 2026, selling an estimated $23.6K and leaving 44,706 shares worth $2.71M. The position accounts for 0.03% of the portfolio, ranked #99.

Horizon Kinetics Asset Management first reported a position in BMY in Q1 2019 and has held it in 29 quarters since. The position peaked at $3.66M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Horizon Kinetics Asset Management held 44,706 shares of Bristol-Myers Squibb worth $2.71M as of Q1 2026.
  • Horizon Kinetics Asset Management sold 404 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.6K.
  • Bristol-Myers Squibb made up 0.03% of Horizon Kinetics Asset Management's portfolio in Q1 2026, its #99 holding.
  • Horizon Kinetics Asset Management first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 29 quarters since.
  • Horizon Kinetics Asset Management's Bristol-Myers Squibb position peaked at $3.66M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Horizon Kinetics Asset Management's 13F filing for Q1 2026, filed 15 May 2026.